Clinical trial
Study of Physiological and High Dose Estradiol in the Treatment of Hormone…
NCT00324259 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00324259 |
|---|---|
| Title | Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer |
| Official title | A Phase II Randomized Study of Physiological (6 mg Daily) and High Dose (30 mg Daily) Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer |
| Lead sponsor | Washington University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | Estradiol |
| Enrollment | 66 |
| Start date | Aug 1, 2004 |
| Primary completion | Mar 1, 2011 |
| Completion | Aug 1, 2014 |
| First posted | May 10, 2006 |
| Last update posted | Feb 16, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: